Analytical and Biological Characterization of Supercoiled Plasmids Purified by Various Chromatographic Techniques by Tumanova, Irina et al.
KU ScholarWorks | http://kuscholarworks.ku.edu
Analytical and biological characterization 
of supercoiled plasmids purified by 
various chromatographic techniques
by Irina Tumanov et al.
KU ScholarWorks is a service provided by the KU Libraries’ Office 
of Scholarly Communication & Copyright.
This is the published version of the article, made available with the 
permission of the publisher.  The original published version can be 
found at the link below.
Irina Tumanov et al. (2005).  Analytical and Biological Characterization 
of Supercoiled Plasmids Purified by Various Chromatographic 
Techniques. DNA and Cell Biology 24(12):819-831.
Published version: http://www.dx.doi.org/10.1089/dna.2005.24.819
Terms of Use: http://www2.ku.edu/~scholar/docs/license.shtml
Please share your stories about how Open Access to this article benefits you.
2005
DNA AND CELL BIOLOGY
Volume 24, Number 12, 2005
© Mary Ann Liebert, Inc.
Pp. 819–831
Analytical and Biological Characterization of Supercoiled
Plasmids Purified by Various Chromatographic Techniques
IRINA TUMANOVA,1 JEAN BOYER,2 S. FERNANDO AUSAR,3 JOSEPH BURZYNSKI,1
DANA ROSENCRANCE,1 JULIE WHITE,1 JASON SCHEIDEL,1 ROSE PARKINSON,2
HENRY MAGUIRE,2 C. RUSSELL MIDDAUGH,3 DAVID WEINER,2 and ANTHONY P. GREEN1
ABSTRACT
Supercoiled plasmids are an important component of gene-based delivery vehicles. A number of production
methods for clinical applications have been developed, each resulting in very high-quality product with low
levels of residual contaminants. There is, however, no consensus on the optimal methods to characterize plas-
mid quality, and further, to determine if these methods are predictive of either product stability or biologi-
cal activity. We have produced two plasmids using four production purification methodologies based on
PolyFlo® and hydrophobic interaction chromatography (HIC), either alone or in tandem processes. In each
case, the product was analyzed using standard molecular biological methods. We also performed a number
of biophysical analyses such as dynamic light scattering (DLS), circular dichroism (CD), Fourier transform
infrared spectroscopy (FTIR), and differential scanning calorimetry (DSC). Minimal differences were detected
among the preparations based on the more standard molecular biological methods. Some small differences
were detected, however, using biophysical techniques, particularly FTIR and DSC, which may reflect small
variations in plasmid tertiary structure and thermal stability. Stability after heat exposure at 60°C, exposure
to fetal bovine serum and long-term storage at 4°C varied between plasmids. One plasmid showed no differ-
ence in stability depending on the production process, but the other showed significant differences. Evalua-
tion in vivo in models for gene immunization and gene therapy showed significant differences in the response
depending on the method of purification. Preparations using a tandem process of PolyFlo used in two sepa-
ration modes provided higher biological activity compared to a tandem HIC/PolyFlo process or either resin
used alone in a single column process. These data indicate that the process by which supercoiled plasmids are
made can influence plasmid stability and biological activity and emphasize the need for more rigorous meth-
ods to evaluate supercoiled plasmids as gene-delivery vehicles.
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INTRODUCTION
NONVIRAL METHODS for the efficient transfer of genes forvaccine and gene therapy applications to specific cell pop-
ulations continue to focus on supercoiled plasmid DNA as the
major therapeutic agent (Kutzler and Weiner, 2004). Applica-
tions have been shown for such varied indications as tubercu-
losis (Derrick et al., 2004), malaria (Smooker et al., 2004; Wang
et al., 2005), Hepatitis B (Mancini-Bourgine et al., 2004) and
HIV (Akahata et. al., 2005; Martin et al., 2005; Singh et al.,
2005; Smith et al., 2005). With the recent emphasis on vac-
cines to address biodefense-associated pathogens, considerable
work has been applied to organisms such as Marburg, Ebola,
Anthrax, and influenza (Riemenschneider et al., 2003; Wang et
al., 2004). In most of these experiments, however, only partial
protection was achieved. As a result, new strategies to improve
biological activity have focused on the plasmid itself or the
means of delivery. For example, “Prime-boost” and multiple
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plasmid strategies have been used to recruit both arms of the
immune system for DNA vaccines and to recruit more appro-
priate cofactors for tumor reduction (Sumida et al., 2004; Mas-
cola et al., 2005).
The potential role of the plasmid production process in plas-
mid stability and biological activity has not been addressed ad-
equately. Many studies have focused on postpurification fac-
tors and incorporated the use of lipid, cationic, or polymeric
condensing agents as a mechanism to increase transfection ef-
ficiency (Gebrekidan et al., 2000; Marshall et al., 2000; Prokop
et al., 2002; Mount et al., 2003; Wiethoff et al., 2004). Fur-
thermore, studies on the stability of naked DNA formulations
are limited. We have been unable to locate any studies that com-
prehensively assess effects on biological activity (Evans et al.,
2000; Knight and Adami, 2003).
There are several methods for large-scale production of su-
percoiled plasmid (scDNA) that can meet the rigorous criteria
for purity, reproducibility, and scaleability, as well as compat-
ibility with cGMP manufacturing requirements. Many of these
processes rely on chromatographic purification of plasmid DNA
and include purification methods such as the one developed at
Puresyn, Inc. This process, based on the chemically inert, non-
porous polymer resin PolyFlo® uses principles of ion-pair re-
versed phase chromatography to simultaneously purify the
scDNA target and eliminate contaminants (Green et al., 1997,
1999). Separation of plasmid isoforms such as open circular
(nicked) plasmids from supercoiled forms is based on differ-
ences in charge density while reduction of residual contami-
nants such as RNA, endotoxin, chromosomal DNA, and pro-
tein is based on differences in hydrophobicity. Other chro-
matographic methods use anion-exchange (AEX) or hydropho-
bic interaction chromatography (HIC) as their primary mode of
purification (Diogo et al., 2001a; Eon-Duval and Burke, 2004).
We and others, however, have shown anion-exchange chro-
matography alone cannot produce the quality required for clin-
ical applications; a second technology is required (Eon-Duval
and Burke, 2004; Urthaler et al., 2004). As a result, processes
that use combinations of AEX and PolyFlo, AEX, and size-ex-
clusion chromatography or AEX and HIC have been developed
(Horn et al., 1995; Stadler et al., 2004).
In this paper, we assess the stability and biological activity
of two different plasmids produced by four different chro-
matographic purification methods. The plasmids were analyzed
in the absence of complexing agents. In conjunction with these
experiments, we applied an extended set of biophysical analyt-
ical techniques to determine if plasmid stability can be pre-
dicted. The implications of these results are discussed.
MATERIALS AND METHODS
Plasmids
The two plasmids used for this study were constructed and
provided by Jean Boyer, Ph.D. and David Weiner, Ph.D. (Uni-
versity of Pennsylvania, Philadelphia, PA). The plasmid pC-
gag02cam is 4877 bp and expresses the HIV-1 clade B gag
gene. The transgene has been RNA optimized. High expression
was achieved by incorporation of a modified CMV promoter
with an optimized enhancer element and the BGH poly(A) tract.
The plasmid pmuIL-12 is 6598 bp and expresses a covalently
linked heterodimeric soluble immune modulator composed of
the mouse 35 kDa (p35 or IL-12a) and 40 kDa (p40 or IL-12b)
chains. The two IL-12 genes were cloned into a dual 
promoter/poly(A) plasmid consisting of the human CMV 
promoter/SV40 poly(A) for IL-12a and the simian CMV pro-
moter/BGH poly(A) for IL-12b. Both plasmids are kanamycin
resistant.
Plasmids were transformed into the Escherichia coli host
strain DH10 using standard molecular biological techniques.
Each plasmid was grown in animal-free Terrific Broth supple-
mented with glycerol (30 g/l) at 37°C under fed-batch condi-
tions in a New Brunswick BioFlo 3000 automated fermentor
(New Brunswick Scientific, New Brunswick, NJ). Controls for
pH, DO and agitation were monitored using the BioCommand
software (New Brunswick Scientific). After overnight fermen-
tation, the biomass was recovered by centrifugation, washed in
TED (25 mM Tris, 10 mM EDTA, and 50 mM Dextrose) and
stored at 20°C until use.
Lysis of recovered biomass
The recovered biomass was lysed using standard Alkali Ly-
sis procedures. In brief, the biomass was resuspended in TED
and lysed by the addition of 0.15 M NaOH/1% SDS. The so-
lution was neutralized by the addition of KAc/NH4Ac, the pre-
cipitate removed by centrifugation and the solution prepared for
chromatography by tangential flow-filtration (TFF) using Pel-
licon 2 ultrafiltration/diafiltration membranes from Millipore
(Bedford, MA). The plasmid was formulated into a buffer ap-
propriate for the subsequent chromatography step.
Chromatography
Four purification methods were used:
1. (PF) PolyFlo chromatography (PolyFlo, 55 , Puresyn, Inc.,
Malvern, PA.) was packed into standard bioprocessing
chromatography columns from Millipore (Bedford, MA) and
performed as previously described (Green et al., 1997;
Green, 1999). In brief, the sample after TFF was formulated
into loading buffer (2 mM TBAP, 1% EtOH, 0.1 M phos-
phate buffer, pH 7.0). After application to PolyFlo, the col-
umn was washed with 7.5% EtOH and the product eluted in
30% ethanol.
2. (PF-FT/PF) The tandem process of PolyFlo-Flow-through
and PolyFlo requires the crude lysate to be formulated in
9% EtOH in phosphate buffer without the ion-pairing agent,
TBAP. Under these conditions, the plasmid will NOT bind.
The unbound fraction was collected, supplemented with
TBAP to a final concentration of 2 mM and applied to
PolyFlo (as in 1 above).
3. (HIC) Hydrophobic interaction chromatography [Toyopearl
Hexyl 650C (Tosoh Biosep, Montgomeryville, PA)] was
used in a nonbinding mode. The crude starting material was
formulated in TE followed by the addition of solid
(NH4)2SO4 to a final concentration of 2.1 M. After applica-
tion to the HIC resin, the unbound material was collected
and formulated into TE by TFF.
4. (HIC/PF) For material proceeding through the tandem HIC-
PolyFlo the post-HIC material was further formulated into
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PolyFlo loading buffer and the plasmid purified as described
in 1 above.
After purification, the plasmid was concentrated by TFF and
formulated into TE for testing.
Analytical methods
Molecular biological techniques. Evaluation of plasmid pu-
rity was assessed by agarose gel electrophoresis in the presence
of EtBr followed by quantitation by scanning densitometry (Al-
phaImager, AlphaInnotech). In brief, the percent (%) DNA ho-
mogeneity was determined by application of a 0.2-g sample.
This assay has a variability of 2.0%. Analysis for residual
RNA, single-stranded DNA, linear DNA, and chromosomal
DNA was also determined by agarose gel electrophoresis, but
used a 1.0-g sample. To improve detection of double-stranded
contaminants, gel electrophoresis in the presence of SYBR
Green I (Molecular Probes, Eugene, OR) was also performed.
The lower limit of detection using this dye is 1 ng. Determi-
nation of dimer supercoiled plasmid was based on selected di-
gestion by Exonuclease III (Epicentre, Madison, WI). Analysis
for residual endotoxin was performed using the LAL gel clot
assay (Associates of Cape Cod, Woods Hole, MA) and for resid-
ual protein by the MicroBCA assay (Pierce, Rockford, IL).
Biophysical techniques
Dynamic light scattering (DLS). Plasmid samples were di-
luted to 1 mg/ml in 10 mM HEPES buffer pH 7.0 and filtered
twice through 0.45-m filters. To prevent dust contamination,
all glassware was exhaustively washed with deionized water.
Measurement of the different plasmid sizes was performed with
a light-scattering system (Brookhaven Instrument Corp.,
Holtzille, NY) employing a 50-milliwatt helium–neon laser
(532 nm) incident upon the sample cell immersed in a bath of
decalin. The scattered light was monitored at 90° to the inci-
dent beam and analyzed using an autocorrelation function gen-
erated by a 522 channel autocorrelator. Data were collected con-
tinuously for five 1-min intervals for each sample and averaged.
The effective hydrodynamic diameter is calculated from the dif-
fusion coefficient by the Stokes-Einstein equation using the
method of cumulants (Choosakonkriang et al., 2003a). Hydro-
dynamic diameters are expressed as the mean  SEM (standard
error of the mean) of five determinations.
Circular dichroism (CD). CD spectra were obtained with
a Jasco 810 spectropolarimeter (Jasco, Easton, MD) equipped
with peltier temperature control and a six-position sample
holder. Spectra were acquired in a 1-mm pathlength quartz cu-
vette at 20°C. Spectra were measured as the average of three
scans at scan rate of 20 nm/min with a resolution of 0.2 nm and
a 2-sec response time. The final concentration of all plasmid
samples was 50 g/ml. Molar elipticity was calculated in terms
of the molar base concentration using an average molecular
mass of 324.5 Da.
Fourier transform infrared spectroscopy (FTIR). FTIR
spectra were obtained with an ABB Bomem FTIR MB series
spectrometer (ABB Bomem, Quebec, Canada). For solution
studies, samples containing 1 to 1.5 mg of plasmid were mea-
sured employing a zinc selenide attenuated total reflectance
(ATR) cell (Thermal A.R.K; SpectraTech, Shelton, CT). For
samples prepared on polyethylene cards, 50 l of plasmid so-
lution (1 mg/ml) was deposited onto the center of the polyeth-
ylene card and dried overnight under mild vacuum. In this case,
transmission mode was used and a background subtraction of
dried TE buffer was performed. Spectra were determined from
256 scans at 4 cm1 resolution. For ATR experiments buffer
spectra were subtracted from all sample spectra for solvent cor-
rection and the association band of water near 2200 cm1 was
used as a reference. Additional data analysis included baseline
correction (1800–800 cm1), seven-point Stavisky-Golay
smoothing and peak position determination.
Differential scanning calorimetry (DSC). DSC was per-
formed with a Microcal Capillary-DSC (Microcal, Northamp-
ton, MA) equipped with an autosampling device. Measurements
consisted of a single scan from 20 to 120°C at 1°C/min under
3 atmospheres of pressure. All samples were diluted in 10 mM
HEPES buffer (pH 7.0) to a final concentration of 1 mg/ml and
degassed under vacuum for at least 10 min. A scan with buffer
in both the sample and reference cells was performed to obtain
the experimental baseline. The data were converted to molar
heat capacity (MHC) using the molecular weight estimated by
agarose gel electrophoresis (the band corresponding to the lin-
ear topoisomer) and assuming an average MW of 324.5 Da per
nucleotide.
Plasmid stability
Plasmid stability was assessed by measurement of the per-
cent monomer supercoiled plasmid after storage at 4°C, heat-
induced nicking at 60°C or exposure to fetal bovine serum
(FBS). For the accelerated studies, plasmid was diluted to 1
mg/ml in TE and incubated at 60°C in a water bath. Samples
were removed over the course of 72 h and assayed for DNA
homogeneity by agarose gel electrophoresis. To assess biolog-
ical stability, plasmid at 0.5 mg/ml was diluted in 5% FBS (JRH,
Lenexa, KS) and incubated at 37°C. Samples were removed
over the course of 8 h and assayed for DNA homogeneity by
agarose gel electrophoresis.
Assessment of biological activity
Immunization study. Mice were immunized with 50 and
150 g of plasmid from each of the four processes (Table 1)
at days 0, 14, and 28. Formulation buffer containing no plas-
mid was used as a control (“mock”). Samples were taken 1
week after each immunization for cellular immunity analysis
and the final immunization humoral immunity. CD8 responses
were evaluated using the Cytokine ELISPOT-CD8 ELISA As-
say using IFN- as a surrogate marker and performed accord-
ing to the manufacturer’s instructions (R&D Systems, Min-
neapolis, MN). CD8 effector cells secrete IFN- following
activation with antigen specific peptides. In this case, MHC
Class I gag epitopes were utilized. Results are presented as the
number of IFN cells/105 spleen cells. Antibody responses to
the p24 antigen were determined by ELISA. In brief, antigen-
coated plates were incubated with mouse antisera and concen-
trations determined using HRP-conjugated goat antimouse IgG
(Sigma, St. Louis, MO). After addition of 3355 TMB
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(Sigma), the plates were read on a Dynatech MR50000 plate
reader at 450nm.
Gene therapy study. A second experiment used the plas-
mid pmuIL-12 in a tumor reduction model of gene therapy. In
brief, CT-26 tumor cells were injected intradermally into Balb/c
mice. When the tumors attained an average diameter of 4–8
mm, they were injected intratumorally with 40 l of pmuIL-12
that day and 3 days later. Comparison was made between the
growth rates of the tumors using different purification processes
and plasmid at different DNA homogeneity. Plasmid purified
by HIC alone was not used in this study based on the results
of the immunization study. Group 1 consisted of plasmids as
they were released (90% DNA homogeneity), Group 2 con-
sisted of plasmids subjected to heat-induced nicking to produce
plasmid at DNA homogeneity target level of 75–80%. Group
3 consisted of plasmids subjected to heat-induced nicking to
produce plasmid at a DNA homogeneity target level of 50–60%.
RESULTS
Purification
Plasmids pCgag02cam and pmuIL-12 were purified by four
different chromatographic processes (Table 1). Both single-col-
umn and tandem-column methods were used. For the tandem-
column processes, the first column, either HIC or PolyFlo,
buffer conditions were used such that the plasmid did not bind.
For HIC chromatography, this was accomplished by adjustment
of the concentration of ammonium sulfate. For PolyFlo-Flow-
Through (PF-FT) chromatography, the sample is applied to the
resin in the absence of the ion-pairing agent, TBAP. Under these
conditions, the resin is used to adsorb denatured and linear plas-
mid, chromosomal DNA, and endotoxin. In both cases, the
flow-through fraction was collected and formulated for appli-
cation to PolyFlo by TFF. 
Analytical results
Molecular biological characterization. The results of the
analysis of the two plasmids purified by the various methods by
molecular biological techniques are shown in Table 1. No sig-
nificant differences among the plasmid preparations after pu-
rification are detected in the presence of EtBr (Table 1) or SYBR
Green I (Fig. 1) except for the DNA homogeneity of the HIC-
alone preparation. No contaminating RNA or chromosomal
DNA is detected using either stain. SYBR Green I exhibits an
increase in sensitivity of up to 25-fold when compared to EtBr
with a lower limit of detection of 1 ng dsDNA. As a result,
the level of contaminating chromosomal DNA is 0.1% (1 ng/1
g sample). Furthermore, SYBR Green I staining is able to re-
solve additional bands, including denatured plasmid (“trefoil”)
in heat-stressed pmuIL-12 indicated by the line in Figure 1B.
Biophysical characterization. Each of the plasmid prepa-
rations was also analyzed by several biophysical techniques, in-
cluding dynamic light scattering (DLS), circular dichroism
(CD), Fourier-transform Infrared spectroscopy (FTIR), and dif-
ferential scanning calorimetry (DSC). These techniques have
been introduced recently to evaluate supercoiled plasmid sta-
bility and quality (Middaugh et al., 1998).
Dynamic light scattering (DLS). To investigate plasmid size
and homogeneity, the mean effective hydrodynamic diameters
and polydispersity indexes were measured by DLS. Overall, the
data show no significant differences for either plasmid purified
by any of the processes tested (Table 2). In general, the sizes of
the resulting plasmid particles were between 85 and 95 nm and
they all display significant heterogeneity (polydispersity 0.2),
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FIG. 1. Agarose gel electrophoresis of plasmids pCgag02cam (A) and pmuIL12 (B). The process used and the %DNA homo-
geneity is provided above each lane.
A B
presumably due to the presence of small amounts of multimeric
isoforms of supercoiled plasmid and nonsupercoiled species (lin-
ear and open circular topoisomers). The degree of polydisper-
sity, however, was similar for all preparations. Particle diame-
ter and polydispersity did not correlate with DNA homogeneity;
thus, plasmid purified by HIC alone, resulting in the lowest
%DNA homogeneity among the preparations, did not result in
the largest particle diameter or the greatest polydispersity.
Circular dichroism (CD) and Fourier transform infrared
spectroscopy (FTIR). Initially, CD spectra of each plasmid were
obtained to see if any alteration in the structure of scDNA was
present among the samples. All plasmid preparations showed
identical DNA spectral features indicative of B-form DNA,
which are characterized by a positive band near 275 nm, a neg-
ative trough around 245 nm and a crossover point near 258 nm
(not illustrated). To further investigate potential structural al-
teration in the DNA, the higher resolution technique of infrared
spectroscopy was employed. The FTIR spectrum of each plas-
mid in solution is displayed in Figure 2. Vibrational features
indicative of B-form DNA include the guanine/thymidine (G/T)
carbonyl stretching band at 1716 cm1 (representative of in-
terstrand base pairing), an asymmetric phosphate stretching vi-
bration at around 1224 cm1, and a sugar-phosphate stretching
vibration at around 970 cm1. Overall, most of these bands are
present in all of the plasmid spectra in solution (Fig. 2) and
were found to have similar positions suggesting that DNA is
mantained in the B-form regardless of the purification process
employed here. No differences were detected by FTIR for plas-
mid pCgag02cam after purification (Fig. 2A). There are, how-
ever, some small differences for the plasmid pmuIL-12 in the
spectral region located between 1300–1200 cm1 (Fig. 2B).
When pmuIL-12 was purified by either PF-FT/PF or PF alone,
a band at 1260 cm1 was detected. When the same plasmid
was purified by HIC/PF or HIC alone, however, the peak at
1260 cm1, was less intense or even undetectable (Fig. 2B).
The origin of these bands is currently obscure but the differ-
ences seen may reflect subtle structural differences. When the
same plasmid was studied in the dry state adsorbed to poly-
ethylene cards, significant alteration in relative band intensities
and bandwidth were observed when compared to the samples
in solution (Fig. 3). Similar results have been previously re-
ported and appear to be related to the dehydration of DNA af-
ter drying on the solid support. In this case, the DNA may adopt
a mixed A and C conformation (Choosakonkriang et al., 2003b).
Comparing the spectra in the dry state of plasmid obtained by
the different purification processes, no clear differences were
observed among the preparations (Fig. 3). Altogether, the re-
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TABLE 2. EFFECTIVE DIAMETER AND POLYDISPERSITY INDEX OF PLASMID
SAMPLES AS DETERMINED BY DYNAMIC LIGHT SCATTERING
pCgag02cam pmuIL-12
DNA Diameter Polydispersity DNA Diameter Polydispersity
Process homogeneity (nm) index homogeneity (nm) index
PolyFlo 96.7% 85.9  0.5 0.238  0.011 98.8% 85.6  2.2 0.287  0.024
PF-FT/PF 96.0% 90.6  1.1 0.278  0.002 95.7% 84.0  2.7 0.295  0.015
HIC 87.1% 96.4  2.4 0.250  0.009 85.6% 87.7  1.1 0.291  0.003
HIC-PF 96.6% 92.0  1.9 0.274  0.009 91.1% 94.3  4.0 0.331  0.036
FIG. 2. FTIR spectra in solution of plasmids pCgag02cam (1.5 mg/ml) (A) and pmuIL-12 (1 mg/ml) (B). The purification
processes are indicated. (PF:PolyFlo; PF-FT/PF: PolyFlo-Flow-through and PolyFlo; HIC/PF: hydrophobic interaction chro-
matography and PolyFlo; HIC: hydrophobic interaction chromatography.) The arrows indicate bands discussed in the text.
sults suggest that if any alterations in the secondary structure
of DNA are induced by the purification process they only are
evident when the molecules are in solution. Many more plas-
mids purified by these methods would need to be examined to
determine the generality of these observations.
Differential scanning calorimetry (DSC). DSC is a sensi-
tive method for determining plasmid thermal stability (Lobo et
al., 2002). Thermograms of all of the plasmids preparations are
shown in Figure 4. Overall, plasmids undergo two melting tran-
sitions within the scan range: scDNA is detected as a broad
transition around 85–95°C, whereas the linear and open circu-
lar species (L/OC) produce a series of transitions between 50
and 70°C (Fig. 4). The plasmid pCgag02cam seems to be com-
paratively more stable than pmuIL-12, since the thermograms
exhibit a higher scDNA melting transition (around 10°C
greater) and a lower contribution from OC/L topoisomers. As
seen with the FTIR data, no difference was detected for plas-
mid pCgag02cam whatever the purification method (Fig. 4A).
A difference was detected, however, for plasmid pmuIL-12
when purified by the PF-FT/PF process compared to the other
three methods (Fig. 4B). The presence of an additional broad
transition at 105°C not seen in any of the other preparations
suggests the existence of a more thermal stable species (Fig.
4B). If the DSC profile provides a true indicator of stability,
then the stability of the plasmid produced by the PF-FT/PF pro-
cess should be different than that of the other preparations. This,
in fact, is confirmed by the accelerated stability studies (see be-
low, Figs. 5 and 6).
Stability studies
Plasmid DNA stability was monitored after storage at 4°C,
by accelerated stability studies after heat exposure at 60°C or
incubation in the presence of 5% FBS. Measurement of DNA
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FIG. 3. FTIR spectra of plasmid pmuIL-12 (1 mg/ml) dried
on polyethylene films. The purification processes are indicated.
(PF:PolyFlo; PF-FT/PF: PolyFlo-Flow-through and PolyFlo;
HIC/PF: hydrophobic interaction chromatography and PolyFlo;
HIC: hydrophobic interaction chromatography.) The band la-
bel with the asterisk indicates incompletely subtracted bands
from the buffer.
FIG. 4. DSC analysis of plasmids pCgag02cam (A) and pmuIL-12 (B). The purification processes are indicated. (PF:PolyFlo;
PF-FT/PF: PolyFlo-Flow-through and PolyFlo; HIC/PF: hydrophobic interaction chromatography and PolyFlo; HIC: hydropho-
bic interaction chromatography.)
homogeneity was determined by agarose gel electrophoresis. In
general, the rates of reduction appear identical between the two
methods of stress induction as well as stability at 4°C. The sta-
bility of the plasmid pCgag02cam at 4°C was identical, 4%
after 14 months, regardless of the purification process. These
results are consistent with the data shown in Figure 5—no dif-
ference is seen in four different preparations of plasmid pC-
gag02cam after stress at 60°C or FBS exposure. In contrast,
significant differences are seen in the stability of plasmid
pmuIL-12 among the three purification processes tested (Fig.
6). The HIC process was not included in the temperature analy-
sis due to a DNA homogeneity level of 90% (Table 1). The
tandem PF-FT/PF process produced plasmid with an initial
DNA homogeneity of 95.7%, and resulted in a highly stable
preparation. An accelerated stability study by heating for as
long as 65 h only reduced the percentage of supercoiling by
30% (Fig. 6A) and a reduction of less than 10% after exposure
to 5% FBS for 7 h (Fig. 6B). Long-term stability at 4°C was
excellent, with a reduction of DNA homogeneity of only 2%
after 8 months (95.7 to 93.6%). In contrast, a 30% reduction in
the supercoiled species was seen for the HIC/PF and PF
processes after heating for only 12 h and a 40% reduction af-
ter 7 h exposure to FBS. These data correlate with the higher
rate of reduction in the supercoiled species after 8 months at
4°C with the HIC/PF process (14%) and the PF process (21%).
Assessment of biological activity
We further evaluated the two plasmids by two different in
vivo studies to determine if the process by which the plasmids
were produced affected biological activity. The first experiment
used the plasmid pCgag02cam in a DNA immunization proto-
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FIG. 5. Stability of plasmid pCgag02cam at 60°C (A) and incubation with 5% FBS (B) obtained by different chromatographic
purification processes. (PF:PolyFlo; PF-FT/PF: PolyFlo-Flow-through and PolyFlo; HIC/PF: hydrophobic interaction chromatog-
raphy and PolyFlo; HIC: hydrophobic interaction chromatography.)
FIG. 6. Stability of plasmid pmuIL-12 at 60°C (A) and incubation with 5% FBS (B) obtained by different chromatographic pu-
rification processes. (PF:PolyFlo; PF-FT/PF: PolyFlo-Flow-through and PolyFlo; HIC/PF: hydrophobic interaction chromatogra-
phy and PolyFlo; HIC: hydrophobic interaction chromatography.)
col followed by analysis for cellular immunity (CD8 Elispot)
and humoral immunity (antibody titers). While there was no de-
tectable difference in either response at the highest dose, 150
g (Figs. 7 and 8), there was a significant difference at the low-
est dose (50 g). The PF-FT/PF process produced the highest
cellular response (Fig. 9) and the highest antibody response
(Fig. 10). These results were not expected, since there are no
detectable differences among the preparations based on the stan-
dard molecular (Table 1) and biophysical analytical analyses
for pCgag02cam (Figs. 2A and 4A) or pmuIL-12 in its dried
state (Fig. 3).
The second study used intratumor injection of plasmid
pmuIL-12 to reduce CT-26 induced tumors. Again, the plasmid
produced by the HIC process was excluded due to the low DNA
homogeneity. As can be seen in Table 3, when plasmid was in-
jected with %DNA homogeneity 90% (group 1), the two tan-
dem processes resulted in a slower rate of tumor growth at days
17 and 21, compared to PolyFlo alone. By day 21 post-injec-
tion, the growth rate of the tumors accelerated, although the
tandem process material appeared to keep tumor growth in
check. The rate of tumor growth in group 1 did not correlate
strictly with DNA homogeneity—the most efficacious response
was seen with the tandem processes [PF-FT/PF (95.7%) and
HIC/PF (91.1%)] compared to PolyFlo alone (98.8% DNA ho-
mogeneity).
When plasmids were subjected to heat-induced nicking to
achieve a DNA homogeneity target level of 75–80% (group 2),
there was no difference in activity between the two tandem
processes at day 17 and both were more biologically active
compared to the single PolyFlo process. By Day 21, only the
PF-FT/PF process material retained its biological activity. Sur-
prisingly, there was minimal difference in the activity of the
plasmid produced by the tandem PF-FT/PF process at both 95.7
and 80% homogeneity. Whether these results can be explained
by the differences in DNA homogeneity (80 versus 74.5% and
77%) or by the increased stability of the plasmid produced by
the PF-FT/PF process (Fig. 6) cannot be determined from the
current data. However, the day 21 data with the group 2 plas-
mids clearly favor the increase in stability as a factor in bio-
logical activity. Group 3 consisted of plasmids subjected to
heat-induced nicking to produce plasmid at a DNA homogene-
ity target level of 50–60% and showed no effect—there was no
reduction of tumor compared to the control suggesting the bi-
ological activity of plasmids below 60% purity may be com-
promised (data not shown).
DISCUSSION
The present investigation focused on the effects of super-
coiled plasmid production on stability and biological activity.
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FIG. 7. CD8 responses after three immunization with 150 g
pCgag02cam (SFU/105 spleen cells  SEM).
FIG. 8. ELISA titers after three immunizations with 150 g pCgag02cam (OD450nm  SEM).
Two plasmids were purified using four different methods—two
single-column procedures and two tandem column procedures.
The plasmid product was not formulated further into complexes
with cations, lipids, or polymers. The product of each proce-
dure was subjected to analysis by standard molecular biologi-
cal methods and a number of biophysical methods (Lobo et al.,
2002, 2003; Braun et al., 2003; Choosakoonkriang et al., 2003a)
and assessed for stability using heat-induced stress. The prod-
uct of each procedure was subsequently used in vivo to assess
the effects of the process on biological activity. Plasmid pmuIL-
12 was subjected to heat-induced nicking to achieve a specific
set point of 75–80% and 55–60% DNA homogeneity (Fig. 1).
Samples at these lower set points were also analyzed using the
biophysical techniques.
No detectable differences were seen in either plasmid pro-
duced by different purification processes using standard mo-
lecular biological analytical techniques (Fig. 1, Table 1). Yet
significant differences in biological activity were seen, partic-
ularly at low doses (Figs. 9 and 10 and Table 3). The results
show a tandem purification process appears to be superior bi-
ologically to a single process. This confirms our previous re-
sults showing the process by which recombinant adenovirus and
recombinant adeno-associated virus is made can have a signif-
icant impact on stability and biological activity (Green et al.,
2002; Rexroad et al., 2003). The degree of plasmid supercoil-
ing appears to compromise biological activity EXCEPT in the
case of the tandem PF-FT/PF process (Table 3). Plasmids with
supercoiling in the 50–60% range showed no biological activ-
ity compared to controls (data not shown). This may reflect
rapid degradation of the plasmid by nucleases. It further sug-
gests there is a minimum threshold of DNA homogeneity for
biological activity.
Assessment of plasmid stability by heat-induced nicking at
60°C, exposure to 5% FBS or “real-time” stability at 4°C
showed a significant difference between the two plasmids (Figs.
5 and 6). The stability of plasmid pCgag02cam was not affected
by the method of purification. In contrast, the stability of plas-
mid pmuIL-12 manifested increased stability when purified by
the tandem PF-FT/PF method, while no difference was seen be-
tween the single PF and tandem HIC/PF method. Interestingly,
the increase in stability of the PF-FT/PF process was seen us-
ing all three methods. These results cannot be explained by the
amount of supercoiled plasmid present or the amount of trefoil
(denatured) plasmid (Fig. 1). This suggests multiple factors can
contribute to plasmid stability, although there is a slight but in-
consistent correlation with residual protein levels. It is in this
context the results of the biophysical characterization of the two
plasmids provide a basis for their inclusion in the analysis of
supercoiled plasmids. CD spectra were identical in both plas-
mids produced by the four purification methods. However,
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FIG. 9. CD8 responses after three immunization with 50 g
pCgag02cam (SFU/105 spleen cells  SEM).
FIG. 10. ELISA titers after three immunizations with 50 g pCgag02cam (OD450nm  SEM).
while no differences were detected in plasmid pCgag02cam by
DLS (Table 3), FTIR (Fig. 2A), or DSC (Fig. 4A) among the
four different preparations, a significant difference was seen in
plasmid pmuIL-12 using FTIR (Fig. 2B) and DSC (Fig. 4B).
The fact that the differences are seen only in the plasmid pmuIL-
12 strongly suggests that the structural and stability alterations
could be plasmid-specific. Significant differences also emerged
after stress or long-term storage at 4°C. Whether these differ-
ences are a direct indicator of stability, a noninformative
byproduct of the samples or simply a coincidence requires fur-
ther study. One possibility is that secondary solutes used dur-
ing some of the purification steps (i.e., ammonium sulfate and
ethanol) have some effect on the structure and stability of the
plasmid, but this requires further investigation.
The processes tested in these experiments exploit differences
in hydrophobicity and charge density among different nucleic
acid species to achieve separation. Hydrophobic interaction
chromatography (HIC) has become an important new separa-
tion modality for the production of supercoiled plasmid (Diogo
et al., 2000, 2001a, 2001b). In particular, HIC can remove con-
taminating RNA, denatured plasmid, host chromosomal DNA,
and endotoxin by exploiting the increase in hydrophobicity of
single-stranded nucleic acid species and endotoxin. Separation
occurs by the application of a salt gradient. PolyFlo uses prin-
ciples of ion-paired reversed-phase chromatography for sepa-
ration of nucleic acid species based on the combination of dif-
ferences in hydrophobicity and charge density (Green et al.,
1997; Green, 1999). Separation occurs by the application of an
organic solvent gradient. The addition of the ion-pairing agent
TBAP to a crude lysate creates the ion-pair bridge between the
phosphate backbone and the hydrophobic PolyFlo matrix. The
strength of that binding is based on the number of phosphates
(size) and charge density. This permits simultaneous separation
of RNA and chromosomal DNA from plasmid, as well as non-
supercoiled isoforms, such as open circular plasmid from su-
percoiled plasmid. As can be seen in Table 1, PolyFlo as a sin-
gle column can produce highly pure supercoiled plasmid.
However, most processes for large-scale and cGMP manufac-
ture of supercoiled plasmids require two columns (Eon-Duval
and Burke, 2004; Urthaler et al., 2004). This provides a degree
of assurance for the removal of contaminants, both detectable
and undetectable. We therefore tested two different tandem
chromatography processes: the PF-FT/PF, and the HIC/PF
methods. In both processes, the crude plasmid sample is ap-
plied to the first resin under conditions where the plasmid will
not bind prior to application to PolyFlo in the binding mode.
For HIC chromatography, this is accomplished by adjusting the
ammonium sulfate concentration to 2.1 M. For PF-FT chro-
matography, this is accomplished by eliminating the ion-pair-
ing agent and increasing the ethanol concentration in the load-
ing buffer. Under these conditions, contaminating linear and
denatured forms of plasmid DNA, chromosomal DNA, as well
as some endotoxin is reduced. In this context, the PF-FT mech-
anism is not dissimilar to HIC. Yet despite this similarity, a dif-
ference is observed between the PF-FT/PF process and the
HIC/PF process in terms of the stability and biological activity
of the final product.
The implications of these results are important for the po-
tential of supercoiled plasmids as gene-delivery vehicles. First,
the process makes a difference. The same plasmid purified by
four different methods resulted in different biological activity.
This means the method used to purify plasmids needs to be con-
sidered very early in the development stage of a gene-based de-
livery vehicle product. Furthermore, the method needs to be
consistent as the development process progresses through scale-
up and clinical phases. Second, different plasmids may have
different stabilities both dependent and independent of the
method of production. As confirmed by this study, supercoiled
plasmids can be unstable when stressed. Any process that can
improve stability will be beneficial. Plasmids are sensitive to
environmental, mechanical, and chemical stresses, each of
which can induce the formation of open circular (“relaxed”) or
even linear forms of plasmids. When plasmids are not com-
plexed with lipids, cations, or polymers, these latter two forms
may be less biologically active than the supercoiled isomer, and
while the data here support that conclusion, there is some con-
troversy concerning this question (Lim et al., 2003). As a re-
sult, the ability to improve plasmid stability will be an impor-
tant contributor to the overall success of this technology.
Improvement in resistance to heat-induced stress may permit
storage at higher temperatures. Resistance to serum nucleases
will improve in vivo half-life. Resistance to mechanical shear
enhances product integrity during transportation and resistance
to chemical exposure will aid in efficacious delivery of these
products to their final in vivo target. Third, the results suggest
a number of factors, including residual protein, can contribute
to plasmid stability and biological activity. The standard meth-
ods currently available for analyzing supercoiled plasmids need
to be supplemented to include other analytical tools such as the
biophysical methods presented here. 
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TABLE 3. TUMOR REDUCTION BY PLASMID PMUIL-12 AT DAYS 17 AND 21 POSTINJECTION BY
DIFFERENT PROCESSES AT DIFFERENT LEVELS OF DNA HOMOGENEITY
% Tumor reduction
Process DNA homogeneity Day 17 Day 21
Group 1 PF-FT/PF 95.7% 80.4% 53.2%
HIC/PF 91.1% 82.7% 54.2%
PF 98.8% 0.4% 23.1%
Group 2 PF-FT/PF 80.0% 74.8% 41.9%
HIC/PF 74.5% 66.9% 0.0%
PF 77.2% 34.8% 6.3%
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